p53 expression in leukoplakia and carcinoma of the tongue

International Journal of Biological Markers

Volumn 21, Issue 2, 2006, Pages 74-80

  Vora, Hemangini H ^a   Trivedi, T I ^a   Shukla, S N ^a   Shah, N G ^a   Goswami, J V ^a   Shah, P M ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

Immunohistochemistry; Leukoplakia; p53; Tongue cancer

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOKING; TONGUE CARCINOMA;

NICOTIANA TABACUM;

EID: 33747033890     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.5628     Document Type: Article

References (44)

1. Kuffer R, Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia. Oral Oncol 2002; 38: 125-30.
2. Brennan JA, Boyle JO, Koch WM, et al. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck. N Engl J Med 1995; 332: 712-7.
3. Field JK, Spandidos DA, Malliri A, Yiagnisis M, Gosney JR, Stell PM. Elevated p53 expression correlates with a history of heavy smoking in squamous cell carcinoma of the head and neck. Br J Cancer 1991; 64: 573-7.
4. Watling DL, Gown AM, Coltrera MD. Over-expression of p53 in head and neck cancer. Head Neck 1992; 14: 437-44.
5. Kaur J, Srivastava A, Ralhan R. Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer 1994; 54: 340-5.
6. Saranath D, Tandle AT, Teni TR, et al. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India. Oral Oncol 1999; 35: 242-50.
7. Partridge M, Kiguwa S, Emilion G, Pateromichelakis S, A'Hern R, Langdon JD. New insights into p53 protein stabilisation in oral squamous cell carcinoma. Oral Oncol 1999; 35: 45-55.
8. Saranath D, Panchal RG, Nair R, Mehta AR, Deo MG. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn J Cancer Res 1989; 80: 430-7.
9. UICC. TNM classification of malignant tumors. UICC Technical Report Series 1980; 5: 2.
10. Broders AC. Microscopic grading of cancer. Surg Clin North Am 1941; 21: 947-62.
11. Patel DD, Bhatavdekar JM, Chikhlikar PR, et al. Node negative breast carcinoma: Hyperprolactinemia and/or overexpression of p53 as an independent predictor of poor prognosis compared to newer and established prognosticators. J Surg Oncol 1996; 62: 86-92.
12. Norusis MJ. In: SPSS for Windows: Advanced statistics, release 6.0. Chicago, IL: SPSS Inc. 1993.
13. Kannan S, Chandran GJ, Pillai KR, et al. Expression of p53 in leukoplakia and squamous cell carcinoma of the oral mucosa: Correlation with expression of Ki67. J Clin Pathol Mol Pathol 1996; 49: M170-5.
14. Piffko J, Bankfalvi A. Immunohistochemical expression of p53 protein in squamous epithelial carcinoma and normal and dysplastic epithelium of the mouth cavity. Mund Kiefer Gesichtschir 1997; 1: 104-7.
15. Trivedy C, Warnakulasuriya KA, Tavassoli M, et al. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med 1998; 27: 72-7.
16. Chiang CP, Lang MJ, Liu BY, et al. Expression of p53 protein in oral submucous fibrosis, oral epithelial hyperkeratosis, and oral epithelial dysplasia. J Formos Med Assoc 2000; 99: 229-34.
17. Cruz IB, Meijer CJ, Snijders PJ, et al. p53 immunoexpression in non-malignant oral mucosa adjacent to oral squamous cell carcinoma: Potential consequences for clinical management. J Pathol 2000; 191: 132-7.
18. Kerdpon D, Rich AM, Reade PC. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis 1997; 3: 86-92.
19. Pillay M, Vasudevan DM, Rao CP, Vidya M. p53 expression in oral cancer: observation of a South Indian study. J Exp Clin Cancer Res 2003; 22: 447-51.
20. Garozzo A, Cutrona D, Palmeri S, et al. The role of p53 tumor suppressor gene as prognostic factor in laryngeal squamous cell carcinoma. Acta Otorhinolaryngol Ital 1999; 19: 342-7.
21. Nigro JM, Baker SJ, Pressinger AC, et al. Mutations in the p53 gene occur in diverse human tumor types. Nature (London) 1989; 342: 705-8.
22. Hall PA, McKeen PH, Menage HD, et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-7.
23. Levine AJ, Perry ME, Chang A, et al. The 1993 Walter Hubert Lecture: The role of the p53 tumor-suppressor gene in tumorigenesis. Br J Cancer 1994; 69: 409-16.
24. Ranasinghe AW, Warnakulasuriya KA, Johnson NW. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol 1993; 29B: 147-50.
25. Shin DM, Lee JS, Lippman SM, et al. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma. J Natl Cancer Inst 1996; 88: 519-29.
26. Kuttan NA, Rosin MP, Ambika K, Priddy RW, Bhakthan NM, Zhang L. High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol 1995; 31B: 169-73.
27. Chow VHW, Yuen PW, Lam KY, et al. p53 expression in oral tongue carcinoma. Cancer Detect Prev 2000; 24 (Suppl 1): 420 (abstr).
28. Atula S, Gernman R, Laippala P, Syrjanen S. Cancer of the tongue in patients younger than 40 years. A distinct entity? Arch Otolaryngol Head Neck Surg 1996; 122: 1313-9.
29. Ibrahim SO, Johannessen AC, Ioris AM, et al. Immunohistochemical detection of p53 in non-malignant and malignant oral lesions associated with snuff dipping in the Sudan and Sweden. Int J Cancer 1996; 68: 749-53.
30. Riva C, Lavieille JP, Reyt E, Brambilla E, Lunardi J, Brambilla C. Different c-myc, c-jun, c-raf and p53 expression in squamous cell carcinoma of the head and neck: implication in drug and radioresistance. Eur J Cancer B Oral Oncol 1995; 31B: 384-91.
31. Xu S, Wu M, Yang Y, et al. Detection of proteins and mRNA of p16, p53 and nm23 in mucoepidermoid carcinoma of salivary gland and their prognostic significance. Zhonghua Bing Li Xue Za Zhi 2001; 30: 273-5.
32. Bongers V, Snow GB, van der Waal I, Braakhuis BJM. Value of p53 expression in oral cancer and adjacent normal mucosa in relation to the occurrence of multiple primary carcinomas. Eur J Cancer B Oral Oncol 1995; 31B: 392-5.
33. Kantola S, Parikka M, Jokinen K, et al. Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-9.
34. Danieli NS, Izhack OB, Hanlon A, et al. p53 alteration in oral tongue cancer is not significantly associated with age at diagnosis or tobacco exposure. Tumori 2005; 91: 346-50.
35. Schwartz JL, Gu X, Kittles RA, et al. Experimental oral carcinoma of the tongue and buccal mucosa: possible biologic markers linked to cancers at two anatomic sites. Oral Oncol 2000; 36: 225-35.
36. Harris CC. P53 tumor suppressor gene: from the basic research laboratory to the clinic - an abridged historical perspective. Carcinogenesis 1996; 17: 1187-98.
37. Chen TM, Defendi V. Functional interaction of p53 with HPV18 E6, c-myc and H-ras in 3T3 cells. Oncogene 1992; 7: 1541-7.
38. Vora HH, Shah NG, Patel DD, et al. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: a multivariate analysis. J Surg Oncol 2003; 82: 34-50.
39. Raybaud-Diogene H, Tetu B, Morency R, Fortin A, Monteil RA. p53 overexpression in head and neck squamous cell carcinoma: review of the literature. Eur J Cancer B Oral Oncol 1996; 32B: 143-9.
40. Saranath D, Bhoite LT, Deo MG. Molecular lesions in human oral cancer: the Indian scene. Eur J Cancer B Oral Oncol 1993; 29B: 107-12.
41. Saranath D. Integrated biology and molecular pathology of oral cancer. In: Saranath D, ed. Contemporary Issues in Oral Cancer. New Delhi: Oxford University Press, 2000; 30-71.
42. Chiang CP, Huang JS, Wang JT, et al. Expression of p53 protein correlates with decreased survival in patients with areca quid chewing and smoking-associated oral squamous cell carcinomas. J Oral Pathol Med 1999; 28: 72-6.
43. Yan JJ, Tzeng CC, Jin YT. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: An immunohistochemical and clinicopathological study. J Oral Pathol Med 1996; 25: 55-9.
44. Pukkila MJ, Kumpulainen EJ, Virtaniemi JA, et al. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: Prognostic implications. Head Neck 2002; 24: 784-91.